HZ/su

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Herpes Zoster

Phase 3

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

CompletedNCT05047770

GlaxoSmithKlineHerpes Zoster

Start: 2021-10-07End: 2022-08-31Updated: 2023-11-13

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

CompletedNCT05219253

GlaxoSmithKlineHerpes Zoster

Start: 2022-02-02End: 2022-12-12Updated: 2025-05-15

Related Papers

Immune response and safety of the adjuvanted recombinant zoster vaccine in adults 50 years of age and older in India: A randomized phase 3 trial

Vaccine2025-02-10

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

Human Vaccines & Immunotherapeutics2024-03-2113 citations

Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview.

2024-02-287 citations

No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial

Clinical Infectious Diseases2023-06-196 citations

NO SAFETY CONCERNS OBSERVED WHEN THE ADJUVANTED RECOMBINANT ZOSTER VACCINE (RZV) AND THE COVID-19 MRNA-1273 BOOSTER WERE CO-ADMINISTERED IN ≥50-YEAR-OLDS

International Journal of Infectious Diseases2023-05-01